• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Aktana Lands $20M For AI-Enabled Decision Support For Life Sciences

Share:

October 1, 2019

– Aktana raises $20M in debt financing from CIBC Innovation Banking for AI-enabled decision support for the global life sciences industry.

– CIBC Innovation Banking delivers strategic advice, cash management, and funding to innovation companies at each stage of their business cycle, from startup to IPO and beyond.

– Using embedded AI and machine learning refined by real-time human insight, Aktana gives life sciences commercial teams the tools and information to anticipate customer needs and coordinate a cohesive experience.

Aktana, an AI-enabled decision support for the global life sciences has closed $20M in debt financing from CIBC Innovation Banking. Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision. CIBC Innovation Banking delivers strategic advice, cash management, and funding to North American innovation companies at each stage of their business cycle, from startup to IPO and beyond. Aktana is backed by HLM Venture Partners, Leerink Partners, SafeGuard Ventures and Starfish Ventures.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

AI-Enabled Decision Support for Life Sciences

Founded in 2011, Aktana is the pioneer in AI-enabled decision support for the global life sciences industry. Using embedded AI and machine learning refined by real-time human insight, Aktana gives life sciences commercial teams the tools and information to anticipate customer needs and coordinate a cohesive experience across channels that is relevant, personalized and highly effective. This allows for better engagement between commercial teams and healthcare providers (HCPs) and ultimately better patient care. With its proven framework for intelligent engagement, Aktana has helped more than half of the world’s top-20 pharmaceutical companies put complex data into context, coordinate channel activity, and generate sales lift of up to 15%.

“Led by a team with deep experience in both technology and life sciences, Aktana is developing innovative and intelligent solutions for its customer base of large life sciences companies,” said Jeff Chapman, a Managing Director in CIBC Innovation Banking’s Menlo Park office. “Aktana is disrupting the industry and we’re pleased to support the next stage of the company’s growth.”

Date: October 01, 2019

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Medline Canada Acquires STAT Healthcare CorporationMedline Canada Acquires STAT Healthcare Corporation
  • Fire & Flower Announces Agreement to Acquire Retail Cannabis Store in North Battleford, SaskatchewanFire & Flower Announces Agreement to Acquire Retail Cannabis Store in North Battleford, Saskatchewan
  • Capital Rx Closes $50M to Expand Pharmacy Benefits Administration PlatformCapital Rx Closes $50M to Expand Pharmacy Benefits Administration Platform
  • Ada Health Secures $90M Series B Funding to Advance Health Assessment TechnologyAda Health Secures $90M Series B Funding to Advance Health Assessment Technology
  • Microsoft Deploys COVID-19 Vaccine Management PlatformMicrosoft Deploys COVID-19 Vaccine Management Platform
  • Tech firms say A.I. can transform health care as we know it. Doctors think they should slow downTech firms say A.I. can transform health care as we know it. Doctors think they should slow down
  • Beleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition AgreementsBeleave Introduces 90 New Cannabis Varieties as it Secures Genetics Acquisition Agreements
  • Recent Breakups Don’t Presage a Pharma-Digital Collaboration Doomsday, Experts sayRecent Breakups Don’t Presage a Pharma-Digital Collaboration Doomsday, Experts say

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications